Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
90,734,822
-
Share change
-
+4,425,762
-
Total reported value
-
$6,629,175,325
-
Put/Call ratio
-
131%
-
Price per share
-
$73.02
-
Number of holders
-
674
-
Value change
-
+$306,052,362
-
Number of buys
-
232
-
Number of sells
-
337
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2023
As of 30 Sep 2023 SPDR SERIES TRUST - S&P BIOTECH (XBI) had 674 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 90,734,822 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, CITIGROUP INC, JPMORGAN CHASE & CO, BNP PARIBAS ARBITRAGE, SNC, Phoenix Holdings Ltd., HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, UBS Group AG, and BROWN ADVISORY INC.
This table shows 674 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.